Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph E Tomaszewski

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|March 26, 2003
Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcomeJon C Mirsalis, Janice Schindler-Horvat, James R Hill, et al.
Analytical Biochemistry|May 7, 2014
Validation of a hypoxia-inducible factor-1 alpha specimen collection procedure and quantitative enzyme-linked immunosorbent assay in solid tumor tissuesSook Ryun Park, Robert J Kinders, Sonny Khin, et al.
Cell Cycle (Georgetown, Tex.)|November 22, 2011
Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agentDiana Nguyen, Maria Zajac-Kaye, Larry Rubinstein, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2010
Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in ratsJoel M Reid, Sarah A Buhrow, Mary J Kuffel, et al.
Molecular Cancer Therapeutics|July 9, 2009
Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivityThomas D Pfister, William C Reinhold, Keli Agama, et al.
Toxicologic Pathology|May 12, 2011
Short-term toxicity study of ST-20 (NSC-741804) by oral gavage in Sprague-Dawley ratsPramod S Terse, Jerry D Johnson, Michael A Hawk, et al.
Cancer Biology & Therapy|October 14, 2009
Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomasSherry X Yang, Shivaani Kummar, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cellsLihua H Wang, Thomas D Pfister, Ralph E Parchment, et al.
Plos One|April 14, 2017
Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® systemPriya Balasubramanian, Robert J Kinders, Shivaani Kummar, et al.
Nature Reviews. Cancer|January 26, 2007
Compressing drug development timelines in oncology using phase '0' trialsShivaani Kummar, Robert Kinders, Larry Rubinstein, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|March 26, 2003
Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcomeJon C Mirsalis, Janice Schindler-Horvat, James R Hill, et al.
Analytical Biochemistry|May 7, 2014
Validation of a hypoxia-inducible factor-1 alpha specimen collection procedure and quantitative enzyme-linked immunosorbent assay in solid tumor tissuesSook Ryun Park, Robert J Kinders, Sonny Khin, et al.
Cell Cycle (Georgetown, Tex.)|November 22, 2011
Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agentDiana Nguyen, Maria Zajac-Kaye, Larry Rubinstein, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2010
Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in ratsJoel M Reid, Sarah A Buhrow, Mary J Kuffel, et al.
Molecular Cancer Therapeutics|July 9, 2009
Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivityThomas D Pfister, William C Reinhold, Keli Agama, et al.
Toxicologic Pathology|May 12, 2011
Short-term toxicity study of ST-20 (NSC-741804) by oral gavage in Sprague-Dawley ratsPramod S Terse, Jerry D Johnson, Michael A Hawk, et al.
Cancer Biology & Therapy|October 14, 2009
Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomasSherry X Yang, Shivaani Kummar, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cellsLihua H Wang, Thomas D Pfister, Ralph E Parchment, et al.
Plos One|April 14, 2017
Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® systemPriya Balasubramanian, Robert J Kinders, Shivaani Kummar, et al.
Nature Reviews. Cancer|January 26, 2007
Compressing drug development timelines in oncology using phase '0' trialsShivaani Kummar, Robert Kinders, Larry Rubinstein, et al.
Pageof 5